Solve FSHD
North America, British Columbia, Canada, Vancouver
Description
Solve FSHD fosters innovation and accelerates critical research toward a treatment for facioscapulohumeral muscular dystrophy.
Investor Profile
Solve FSHD has backed more than 4 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 75% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Seed, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Japan.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 2 rounds in the past year.
Stage Focus
- Series B (50%)
- Seed (25%)
- Post Ipo Equity (25%)
Country Focus
- United States (75%)
- Japan (25%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Biopharma
- Health Diagnostics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Solve FSHD frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
What are some of recent deals done by Solve FSHD?
Find More Investors Like Solve FSHD
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
